PROPOFOL
Propofol
Sir Ganga Ram HospitalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Propofol cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
RAMIFENTANYL Tri-Service General Hospital | N/A | D |
Desflurane Zhongnan Hospital | N/A | D |
Same molecule, other indications
PROPOFOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →